NCT04487288 is a NA clinical trial of SONAZOID in Contrast Media, Liver, Biopsy, Fusion, sponsored by Seoul National University Hospital.

Who is sponsoring NCT04487288?

NCT04487288 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT04487288?

Interventions in NCT04487288: SONAZOID.

What condition does NCT04487288 study?

NCT04487288 studies Contrast Media, Liver, Biopsy, Fusion.

Is NCT04487288 still recruiting?

NCT04487288 is currently status unknown. Last updated 8 April 2021.

Last reviewed 2021-04-08 · How we verify

NCT04487288

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Added Value in Combined Use of Fusion Imaging and Contrast-enhanced Ultrasonography

Status unknown NA Last updated 8 April 2021

What this trial tests

NA trial testing SONAZOID in Contrast Media, Liver, Biopsy, Fusion in 44 participants. Status unknown.

Timeline

2 June 2020

Primary endpoint
1 March 2022

30 December 2022

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	44
Start date	2 June 2020
Primary completion	1 March 2022
Estimated completion	30 December 2022
Sites	1 location across South Korea

Drugs / interventions tested

SONAZOID

Conditions studied

Contrast Media, Liver, Biopsy, Fusion — all drugs for Contrast Media, Liver, Biopsy, Fusion →

Sponsor

Seoul National University Hospital

Who can join

Adults 18 to 85, any sex, with Contrast Media, Liver, Biopsy, Fusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

So far, there have been studies showing that the CEUS-grafted technique has added value in biopsy and RFA, but no studies have compared the group using only fusion and the group using CEUS+fusion. Therefore, the additional added value of CEUS will be evaluated by comparing the two groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04487288 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 8 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04487288.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing